| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| MousePheno | abnormal collagen level | 5.71e-06 | 16 | 108 | 4 | MP:0020252 | |
| Domain | Myosin_head_motor_dom | 1.34e-04 | 38 | 129 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.34e-04 | 38 | 129 | 4 | PS51456 | |
| Domain | Myosin_head | 1.34e-04 | 38 | 129 | 4 | PF00063 | |
| Domain | MYSc | 1.34e-04 | 38 | 129 | 4 | SM00242 | |
| Domain | Rhs_assc_core | 1.41e-04 | 3 | 129 | 2 | IPR022385 | |
| Domain | PH_dom-like | IQSEC3 MYO7B EPS8L1 PLEKHM1 ARHGAP22 PTK2B PTPN14 NECAP2 OSBPL8 SPRED1 ARHGAP25 | 1.82e-04 | 426 | 129 | 11 | IPR011993 |
| Domain | Tox-GHH_dom | 2.81e-04 | 4 | 129 | 2 | IPR028916 | |
| Domain | LRRC37AB_C | 2.81e-04 | 4 | 129 | 2 | IPR029423 | |
| Domain | Tox-GHH | 2.81e-04 | 4 | 129 | 2 | PF15636 | |
| Domain | LRRC37AB_C | 2.81e-04 | 4 | 129 | 2 | PF14914 | |
| Domain | Ten_N | 2.81e-04 | 4 | 129 | 2 | IPR009471 | |
| Domain | Ten_N | 2.81e-04 | 4 | 129 | 2 | PF06484 | |
| Domain | LRRC37_N | 2.81e-04 | 4 | 129 | 2 | IPR032754 | |
| Domain | TENEURIN_N | 2.81e-04 | 4 | 129 | 2 | PS51361 | |
| Domain | LRRC37 | 2.81e-04 | 4 | 129 | 2 | PF15779 | |
| Domain | LRRC37A/B-like | 2.81e-04 | 4 | 129 | 2 | IPR015753 | |
| Domain | - | 3.62e-04 | 49 | 129 | 4 | 1.20.80.10 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 3.91e-04 | 50 | 129 | 4 | IPR014352 | |
| Domain | IQ_motif_EF-hand-BS | 4.00e-04 | 90 | 129 | 5 | IPR000048 | |
| Domain | IQ | 4.65e-04 | 93 | 129 | 5 | PS50096 | |
| Domain | YD | 4.67e-04 | 5 | 129 | 2 | IPR006530 | |
| Domain | EGF_extracell | 7.85e-04 | 60 | 129 | 4 | IPR013111 | |
| Domain | EGF_2 | 7.85e-04 | 60 | 129 | 4 | PF07974 | |
| Domain | EFh | 8.06e-04 | 158 | 129 | 6 | SM00054 | |
| Domain | EF_HAND_2 | 1.13e-03 | 231 | 129 | 7 | PS50222 | |
| Domain | EF_hand_dom | 1.16e-03 | 232 | 129 | 7 | IPR002048 | |
| Pubmed | VPS18 MYBBP1A SRSF5 KRT18 MYO9B MARK3 U2AF1L4 PSMC2 GRB2 SHMT2 MRPL4 CDC37 PTPN14 MYH14 ABCE1 MICAL2 IGHMBP2 PRDX1 CTNND1 ACBD3 FKBP4 | 7.96e-09 | 1247 | 130 | 21 | 27684187 | |
| Pubmed | IQSEC3 PDE1C VPS18 MYBBP1A SRSF5 MARK3 GRB2 ACTR3B GRM2 PPIB PTK2B TENM4 GUCY1A2 MYH14 MICAL2 PRDX1 OSBPL8 KMT2A PYGB EXOC1 CTNND1 PRRC2B | 1.72e-08 | 1431 | 130 | 22 | 37142655 | |
| Pubmed | EPHX1 MYBBP1A GALK1 PSMC2 L2HGDH PPIB CDC37 JUN ABCE1 PYGB CTNND1 ACBD3 | 8.48e-07 | 534 | 130 | 12 | 35032548 | |
| Pubmed | 1.77e-06 | 7 | 130 | 3 | 12915301 | ||
| Pubmed | GALK1 SRSF5 KRT18 MARK3 MYO19 TTI2 PSMC2 GRB2 SHMT2 L2HGDH MRPL4 CDC37 FDFT1 COMMD2 PRDX1 OSBPL8 KMT2A EXOC1 PRRC2B | 1.79e-06 | 1440 | 130 | 19 | 30833792 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYBBP1A GALK1 KRT18 MYO9B MYO19 CAPN2 PSMC2 SHMT2 PPIB CDC37 PTPN14 MYH14 ABCE1 MICAL2 PRDX1 PYGB EXOC1 CTNND1 | 3.08e-06 | 1353 | 130 | 18 | 29467282 |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | GALK1 SHMT2 LCP1 PPIB UTP25 MYH14 ABCE1 FDFT1 OSBPL8 PYGB CTNND1 FKBP4 | 3.19e-06 | 607 | 130 | 12 | 39147351 |
| Pubmed | 3.99e-06 | 63 | 130 | 5 | 17672918 | ||
| Pubmed | Defining human ERAD networks through an integrative mapping strategy. | 4.21e-06 | 173 | 130 | 7 | 22119785 | |
| Pubmed | MYBBP1A SRSF5 PSMC2 LCP1 UTP25 MYH14 ABCE1 OSBPL8 KMT2A PYGB FKBP4 PRRC2B | 6.67e-06 | 653 | 130 | 12 | 22586326 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MYBBP1A KRT18 ZMYND8 PEPD PSMC2 SHMT2 CDC37 ABCE1 PRDX1 KMT2A CTNND1 ACBD3 FKBP4 PRRC2B | 1.13e-05 | 934 | 130 | 14 | 33916271 |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 35484136 | ||
| Pubmed | Cooperation of MLL1 and Jun in controlling H3K4me3 on enhancers in colorectal cancer. | 1.39e-05 | 2 | 130 | 2 | 38012744 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 19047684 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 10354709 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 19965632 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 24369359 | ||
| Pubmed | Nonsyndromic hearing impairment: unparalleled heterogeneity. | 1.39e-05 | 2 | 130 | 2 | 9106521 | |
| Pubmed | A case of interdigitating dendritic cell sarcoma studied by whole-exome sequencing. | 1.39e-05 | 2 | 130 | 2 | 30099721 | |
| Pubmed | 1.80e-05 | 14 | 130 | 3 | 8022818 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | SPEG ZMYND8 GRB2 L2HGDH LCP1 PPIB IGHMBP2 OSBPL8 KMT2A CTNND1 | 1.87e-05 | 497 | 130 | 10 | 36774506 |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | MYO9B MARK3 PSMC2 LAMA3 EPS8L1 LCP1 MRPL4 MYH14 ABCE1 SEMA3B FKBP4 PRRC2B | 2.07e-05 | 732 | 130 | 12 | 34732716 |
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | 2.75e-05 | 231 | 130 | 7 | 36597993 | |
| Pubmed | 2.84e-05 | 94 | 130 | 5 | 32062451 | ||
| Pubmed | 3.52e-05 | 329 | 130 | 8 | 35562734 | ||
| Pubmed | 3.75e-05 | 332 | 130 | 8 | 37433992 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | VPS18 SRSF5 MARK3 RBL1 MAPKAPK2 GRB2 CDC37 PTK2B UTP25 ABCE1 OSBPL8 KMT2A CTNND1 | 3.87e-05 | 910 | 130 | 13 | 36736316 |
| Pubmed | Monitoring protein-protein interactions in mammalian cells by trans-SUMOylation. | 4.00e-05 | 18 | 130 | 3 | 21675959 | |
| Pubmed | SRSF5 RBL1 GRB2 SHMT2 PPIB MRPL4 CDC37 ARHGAP22 JUN KMT2A ARHGAP25 CTNND1 FKBP4 | 4.14e-05 | 916 | 130 | 13 | 32203420 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 21368133 | ||
| Pubmed | Identification and characterization of ARHGAP24 and ARHGAP25 genes in silico. | 4.15e-05 | 3 | 130 | 2 | 15254788 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 9260931 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 21357692 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 19924227 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 27210483 | ||
| Pubmed | Detection of proteins that bind to the leucine zipper motif of c-Myb. | 4.15e-05 | 3 | 130 | 2 | 8302594 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 9447996 | ||
| Pubmed | PYGB Promoted Tumor Progression by Regulating Wnt/β-Catenin Pathway in Gastric Cancer. | 4.15e-05 | 3 | 130 | 2 | 32462986 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 18664273 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 37543013 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MARK3 MAPKAPK2 PEPD LAMA3 L2HGDH H6PD ACVR2B TECTA PLEKHM1 B4GALT1 MYH14 MICAL2 SEMA3B FNIP1 RASEF CTNND1 PRDM15 | 4.18e-05 | 1489 | 130 | 17 | 28611215 |
| Pubmed | KCTD9 MYBBP1A MARK3 ZMYND8 PSMC2 GRB2 PPIB CDC37 ABCE1 PRDX1 EXOC1 NLRC3 | 5.45e-05 | 809 | 130 | 12 | 32129710 | |
| Pubmed | 6.46e-05 | 463 | 130 | 9 | 34901782 | ||
| Pubmed | 7.48e-05 | 472 | 130 | 9 | 38943005 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | GALK1 SRSF5 CAPN2 PSMC2 GRB2 SHMT2 LCP1 CDC37 PTPN14 ABCE1 OSBPL8 ACBD3 PRRC2B | 7.70e-05 | 974 | 130 | 13 | 28675297 |
| Pubmed | Ras protects Rb family null fibroblasts from cell death: a role for AP-1. | 8.28e-05 | 4 | 130 | 2 | 14688262 | |
| Pubmed | Research progress in pathogenic genes of hereditary non-syndromic mid-frequency deafness. | 8.28e-05 | 4 | 130 | 2 | 27142990 | |
| Pubmed | Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues. | 8.28e-05 | 4 | 130 | 2 | 10225957 | |
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 36384119 | ||
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 15661758 | ||
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 25132599 | ||
| Pubmed | Identification of FHOD1-binding proteins and mechanisms of FHOD1-regulated actin dynamics. | 8.28e-05 | 4 | 130 | 2 | 15095401 | |
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 37894811 | ||
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 10329689 | ||
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 22419166 | ||
| Pubmed | Mapping GRB2, a signal transduction gene in the human and the mouse. | 8.28e-05 | 4 | 130 | 2 | 7806216 | |
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 9032244 | ||
| Pubmed | Genes involved in glucocorticoid receptor signalling affect susceptibility to mood disorders. | 8.28e-05 | 4 | 130 | 2 | 32400287 | |
| Pubmed | RUTBC2 protein, a Rab9A effector and GTPase-activating protein for Rab36. | 8.28e-05 | 4 | 130 | 2 | 22637480 | |
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 9374537 | ||
| Pubmed | All four members of the Ten-m/Odz family of transmembrane proteins form dimers. | 8.28e-05 | 4 | 130 | 2 | 12000766 | |
| Pubmed | SRSF5 MYO19 GRB2 METTL14 MRPL4 UTP25 PRDX1 RAB2B CTNND1 FKBP4 PRRC2B | 9.01e-05 | 723 | 130 | 11 | 34133714 | |
| Pubmed | 9.63e-05 | 488 | 130 | 9 | 31324722 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | COL11A2 GALK1 KRT18 MARK3 CETN2 PSMC2 GRB2 SHMT2 PPIB CDC37 ABCE1 CTNND1 PRRC2B | 1.05e-04 | 1005 | 130 | 13 | 19615732 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MYBBP1A GALK1 SRSF5 KRT18 CETN2 PSMC2 SHMT2 LCP1 PPIB CDC37 PRDX1 RAB2B ACBD3 FKBP4 | 1.06e-04 | 1149 | 130 | 14 | 35446349 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | GALK1 CAPN2 MXRA8 PEPD GRB2 SHMT2 EPS8L1 TECTA LCP1 PPIB B4GALT1 MYH14 FKBP4 | 1.17e-04 | 1016 | 130 | 13 | 19056867 |
| Pubmed | 1.19e-04 | 67 | 130 | 4 | 22046132 | ||
| Pubmed | 1.19e-04 | 127 | 130 | 5 | 30442766 | ||
| Pubmed | MYBBP1A GALK1 GPAA1 MYO9B PSMC2 PPIB B4GALT1 MYH14 ABCE1 IGHMBP2 OSBPL8 PYGB EXOC1 ACBD3 | 1.26e-04 | 1168 | 130 | 14 | 19946888 | |
| Pubmed | Dynamin reduces Pyk2 Y402 phosphorylation and SRC binding in osteoclasts. | 1.38e-04 | 5 | 130 | 2 | 19380485 | |
| Pubmed | 1.38e-04 | 5 | 130 | 2 | 12149229 | ||
| Pubmed | 1.38e-04 | 5 | 130 | 2 | 15319445 | ||
| Pubmed | Beta-chemokine receptor CCR5 signals through SHP1, SHP2, and Syk. | 1.38e-04 | 5 | 130 | 2 | 10747947 | |
| Pubmed | Identification of interaction partners of the cytosolic polyproline region of CD95 ligand (CD178). | 1.38e-04 | 5 | 130 | 2 | 12023017 | |
| Pubmed | 1.38e-04 | 5 | 130 | 2 | 31913121 | ||
| Pubmed | 1.40e-04 | 27 | 130 | 3 | 18478268 | ||
| Pubmed | MYBBP1A SRSF5 CETN2 MYO19 CDC37 PTPN14 MICAL2 FDFT1 CTNND1 FKBP4 | 1.42e-04 | 634 | 130 | 10 | 34591612 | |
| Pubmed | The deubiquitinase USP9X regulates FBW7 stability and suppresses colorectal cancer. | 1.49e-04 | 71 | 130 | 4 | 29346117 | |
| Pubmed | 1.54e-04 | 407 | 130 | 8 | 12693553 | ||
| Pubmed | 1.57e-04 | 72 | 130 | 4 | 16923123 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | 1.67e-04 | 647 | 130 | 10 | 26618866 | |
| Pubmed | 1.94e-04 | 421 | 130 | 8 | 36976175 | ||
| Pubmed | 1.95e-04 | 222 | 130 | 6 | 35941108 | ||
| Pubmed | 2.05e-04 | 224 | 130 | 6 | 32941674 | ||
| Pubmed | The same pocket in menin binds both MLL and JUND but has opposite effects on transcription. | 2.06e-04 | 6 | 130 | 2 | 22327296 | |
| Pubmed | 2.06e-04 | 6 | 130 | 2 | 9774338 | ||
| Pubmed | 2.06e-04 | 6 | 130 | 2 | 20376328 | ||
| Pubmed | 2.06e-04 | 6 | 130 | 2 | 8816797 | ||
| Pubmed | 2.06e-04 | 6 | 130 | 2 | 2776480 | ||
| Pubmed | Specific binding of tetratricopeptide repeat proteins to the C-terminal 12-kDa domain of hsp90. | 2.06e-04 | 6 | 130 | 2 | 9660753 | |
| Pubmed | EPHX1 GALK1 SRSF5 PSMC2 SHMT2 PPIB MYH14 ABCE1 PRDX1 PYGB FKBP4 | 2.24e-04 | 803 | 130 | 11 | 36517590 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | MYBBP1A GALK1 SHMT2 PPIB CDC37 MYH14 ABCE1 PRDX1 KMT2A PYGB FKBP4 | 2.34e-04 | 807 | 130 | 11 | 30575818 |
| Pubmed | 2.49e-04 | 437 | 130 | 8 | 20562859 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | MYBBP1A GALK1 PSMC2 GRB2 SHMT2 L2HGDH MCL1 MRPL4 ABCE1 FDFT1 PRDX1 PYGB CTNND1 ACBD3 | 2.67e-04 | 1257 | 130 | 14 | 37317656 |
| Pubmed | 2.68e-04 | 560 | 130 | 9 | 35241646 | ||
| Pubmed | Tlag2, an N-methyl-N-nitrosourea susceptibility locus, maps to mouse chromosome 4. | 2.88e-04 | 7 | 130 | 2 | 11813303 | |
| Pubmed | A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. | 2.88e-04 | 7 | 130 | 2 | 14586460 | |
| Pubmed | 2.88e-04 | 7 | 130 | 2 | 9367879 | ||
| Pubmed | Chromosomal localization of the three members of the jun proto-oncogene family in mouse and man. | 2.88e-04 | 7 | 130 | 2 | 2108401 | |
| Pubmed | 2.88e-04 | 7 | 130 | 2 | 11212352 | ||
| GeneFamily | EF-hand domain containing | 1.36e-04 | 219 | 93 | 7 | 863 | |
| GeneFamily | RAB, member RAS oncogene GTPases | 3.49e-04 | 65 | 93 | 4 | 388 | |
| Coexpression | GSE27786_ERYTHROBLAST_VS_MONO_MAC_UP | 7.32e-06 | 200 | 130 | 8 | M4877 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | KRT18 MYO9B SPEG CAPN2 MXRA8 MCL1 LCP1 PPIB TBC1D9 STAB1 ARHGAP22 PTK2B JUN MICAL2 SEMA3B OSBPL8 SPRED1 ARHGAP25 NLRC3 | 1.21e-05 | 1242 | 130 | 19 | M1920 |
| Coexpression | BUSSLINGER_GASTRIC_ISTHMUS_CELLS | KRT18 TENT5A ANO1 LAMA3 B4GALT1 CDC37 MYH14 PRDX1 SEMA3B RASEF SGSM3 | 1.85e-05 | 458 | 130 | 11 | M40010 |
| Coexpression | DORSAM_HOXA9_TARGETS_DN | 1.87e-05 | 32 | 130 | 4 | M6051 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | KRT18 MYO9B SPEG CAPN2 MXRA8 MCL1 LCP1 PPIB TBC1D9 STAB1 ARHGAP22 PTK2B JUN MICAL2 SEMA3B OSBPL8 SPRED1 ARHGAP25 NLRC3 | 2.70e-05 | 1316 | 130 | 19 | MM1052 |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.69e-08 | 169 | 130 | 8 | 665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.69e-08 | 169 | 130 | 8 | 6614c9851537e4c21b1e45ff0cc3bad07ef9d034 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-07 | 194 | 130 | 8 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-07 | 194 | 130 | 8 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-07 | 196 | 130 | 8 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-07 | 196 | 130 | 8 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 1.30e-07 | 199 | 130 | 8 | 0447f8f53389fe7c6ddc04a97d86e74122ea16f4 | |
| ToppCell | P07-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.41e-07 | 153 | 130 | 7 | 5501095bcf73080872ae01128f21399f9cfc5dd1 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.81e-07 | 173 | 130 | 7 | 45808cf69122c16b9d2b5ffa06d15392c55954b7 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.81e-07 | 173 | 130 | 7 | 7fa9dbcb258c3ab974490063951620e2def03db1 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.44e-07 | 175 | 130 | 7 | 442f261a3b2c4d2523f7d4089178f8c79cac2f0f | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.44e-07 | 175 | 130 | 7 | 35fb7735dd3355476fe60404833cb60bd066bcf1 | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.14e-06 | 183 | 130 | 7 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | P03-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.57e-06 | 192 | 130 | 7 | be5e246b2350398b985767b2fbede17a8dd8cc44 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-06 | 195 | 130 | 7 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-06 | 195 | 130 | 7 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type | 1.86e-06 | 197 | 130 | 7 | 3896729740d151f0eb845f1961c7b969bfbdd28d | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.26e-06 | 138 | 130 | 6 | 611fe0fb284e12678f9c47a0bdbfc367a93c52b3 | |
| ToppCell | COVID-19_Mild-Neu_0|World / 5 Neutrophil clusters in COVID-19 patients | 3.54e-06 | 140 | 130 | 6 | 93f024473b1bb3bf93ae776fd6a8fc5e93d013f0 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT1_Precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 6.13e-06 | 154 | 130 | 6 | 8a643d91896af9b630a715fb284c1523d01ad1a3 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 168 | 130 | 6 | 06dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 168 | 130 | 6 | 1002f058a340763e3d8de0bd1f0547a903526ec6 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-05 | 171 | 130 | 6 | e01bef6d814c0b7bd015c71e20a194e2dec68377 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Hematologic-erythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 100 | 130 | 5 | f305bc37f97617007b59bf06d288dd14c3c06e42 | |
| ToppCell | facs-Heart-RV-18m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 175 | 130 | 6 | bde002379088c0407afd0f3dae60b6a166683957 | |
| ToppCell | P03-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.31e-05 | 176 | 130 | 6 | f3a54038cde58326f1caed96ecca33c141bcc8b3 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.36e-05 | 177 | 130 | 6 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.36e-05 | 177 | 130 | 6 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 1.45e-05 | 179 | 130 | 6 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.49e-05 | 180 | 130 | 6 | baa5825e6ce23a98d9c21d024a4b0ab8ba353d0c | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.49e-05 | 180 | 130 | 6 | 2d608b9394d28d19cfc85c6ac94003d5177c8a92 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.49e-05 | 180 | 130 | 6 | 0f9b27054358c4737eed06c8ea01987cccc3cb55 | |
| ToppCell | droplet-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.54e-05 | 181 | 130 | 6 | 2c44c41b4e8a75ebdbaeb0c6cc5a03f17c44758c | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-05 | 182 | 130 | 6 | e97681a4102f3095d5d9e90ad70f1dc46e90983a | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.69e-05 | 184 | 130 | 6 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.69e-05 | 184 | 130 | 6 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.69e-05 | 184 | 130 | 6 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT2_Progenitor|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-05 | 185 | 130 | 6 | 8ca1374501eca01d8468130b74d50abfd4329fbe | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 185 | 130 | 6 | 30df02fbe2828e3c4f3e5c4cda855e74fb31be39 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-05 | 185 | 130 | 6 | fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3 | |
| ToppCell | droplet-Fat-Scat-21m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-05 | 186 | 130 | 6 | 59710cff3f6f7c318ee2524b44c1a909f312c25e | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-05 | 186 | 130 | 6 | 1e67bfb248366d7395efdd2d5e70a97bdb2e68af | |
| ToppCell | droplet-Fat-Scat-21m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-05 | 186 | 130 | 6 | de88fafac51049ec1920695844d8ce8057940272 | |
| ToppCell | P15-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.80e-05 | 186 | 130 | 6 | 521e6e007bbae73e7328153aa170cf04ca3c1093 | |
| ToppCell | droplet-Fat-Scat-21m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-05 | 186 | 130 | 6 | 7ff73ab8fed5da779ee9c7bd2e14a8363edb7509 | |
| ToppCell | P28-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.85e-05 | 187 | 130 | 6 | a4b41904ba05eb76212c949fc3ac197f906c8351 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.91e-05 | 188 | 130 | 6 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 188 | 130 | 6 | 842982de2197770f999a70083ed9fca40ac22d79 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.91e-05 | 188 | 130 | 6 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 188 | 130 | 6 | a0815eaf68eedd6e5ec4af520df80a6ab4eb0864 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-Plasma_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.91e-05 | 188 | 130 | 6 | 34873972dff9284dfcd26bb698c9d1df007f1cbb | |
| ToppCell | HSPCs-Ery_prog.|HSPCs / Lineage and Cell class | 1.97e-05 | 189 | 130 | 6 | 37d2c45debed1564a40a1085b8b310c50923b9e7 | |
| ToppCell | droplet-Heart-nan-24m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 189 | 130 | 6 | 1137583e21d874c201c20581ba1995e2bfa3de59 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 190 | 130 | 6 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | droplet-Heart-nan-24m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 190 | 130 | 6 | 7068754c29f63a331e2b6c54715f3b26f37ad32b | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.02e-05 | 190 | 130 | 6 | 3b9abc25b17e7295356ded57ff2ca519fa9f2686 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.02e-05 | 190 | 130 | 6 | 63018acb7ad80415e861643162abdc2e55968ee4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 190 | 130 | 6 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 190 | 130 | 6 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.09e-05 | 191 | 130 | 6 | 95ae42d145adb478d886a2259baacc713cd6587b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-05 | 191 | 130 | 6 | baa70781633a3fe5bf987f9d8dff3884f5167e7f | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.09e-05 | 191 | 130 | 6 | ce76b156b153a2c7c9f2fb8e563b69c81073fbe5 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.09e-05 | 191 | 130 | 6 | c006f5a6e3a32b79ac99a78304bdd5116fc0d5e0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-05 | 191 | 130 | 6 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-05 | 191 | 130 | 6 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | P07-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.09e-05 | 191 | 130 | 6 | 0f360766490bef3495c42f6421b22a988cfc68fb | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.09e-05 | 191 | 130 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | droplet-Heart-nan-18m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-05 | 192 | 130 | 6 | 0b9b2eaed45456d7d74ce78a64ef4a26ac2458fb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-05 | 192 | 130 | 6 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.15e-05 | 192 | 130 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.15e-05 | 192 | 130 | 6 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-05 | 194 | 130 | 6 | 4579b4a44f7c731553a284843c296866027d7c0e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-05 | 194 | 130 | 6 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.28e-05 | 194 | 130 | 6 | a281ebab117589fc922ead0a712cfe0a844c94ac | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.28e-05 | 194 | 130 | 6 | ad3eb98f94a007c5988ede06238255f5b03bee6e | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-05 | 194 | 130 | 6 | 715e02e5f3250b1bfdc26b7dfd656ba4e705ea84 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-05 | 194 | 130 | 6 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-05 | 195 | 130 | 6 | 42bfdff88da1d07828c0ad65d412fb1752f0cee4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-05 | 195 | 130 | 6 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-05 | 195 | 130 | 6 | 09df40ff9b493170861b3f6e57a942a834655b5c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-05 | 195 | 130 | 6 | 34a9462f4e843f3065cc58c17ad71c1b5b836ae1 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-05 | 195 | 130 | 6 | 3d6d3de8ada6dce3dc789c15b50cc066e7100496 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-05 | 196 | 130 | 6 | b8759e6231e0254797d6c30930407b79440c57bb | |
| ToppCell | Epithelial-A_(AT1)|World / shred on cell class and cell subclass (v4) | 2.41e-05 | 196 | 130 | 6 | 484bbc6b1f58bc260964babb949d14f5df101393 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-05 | 196 | 130 | 6 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-05 | 196 | 130 | 6 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 196 | 130 | 6 | 9554ac6eb5f381bcde3ba40c32aa3fc340974540 | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 2.48e-05 | 197 | 130 | 6 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.48e-05 | 197 | 130 | 6 | e42910a653a1b5bd90c090e9665a84871ed2873f | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type | 2.48e-05 | 197 | 130 | 6 | a0f8a992282a6d64890f5574c7c9741fcb38dadd | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.48e-05 | 197 | 130 | 6 | ad6f047d003c08413264f39a30ba0f7639a257cd | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2|Control_saline / Treatment groups by lineage, cell group, cell type | 2.48e-05 | 197 | 130 | 6 | b8f62fcd6eb8f47b3cc41f616126f82c68a36e87 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.48e-05 | 197 | 130 | 6 | 1638959d7aecb9fc5285eb7e4a3103ca437989e2 | |
| ToppCell | NS-critical-LOC-Myeloid-Macrophage|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.48e-05 | 197 | 130 | 6 | 5fb0696376a5501b7c87e0f2f5e4fff3da2903f2 | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.55e-05 | 198 | 130 | 6 | ea34096bee852a7e996f097fa279381afa8f86ff | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor|Control_saline / Treatment groups by lineage, cell group, cell type | 2.55e-05 | 198 | 130 | 6 | 030ef63e2fc5b3d601c1a48462d797aa19ee7ff5 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.55e-05 | 198 | 130 | 6 | 1282db321e27499d310339d6383974614e295a20 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 2.55e-05 | 198 | 130 | 6 | 827aa9d919bf6d670961e5501e17d351676127e3 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 2.55e-05 | 198 | 130 | 6 | 6b6572deeca98ccb015f2aa3c5ce27de44445f74 | |
| ToppCell | 18-Airway|18 / Age, Tissue, Lineage and Cell class | 2.55e-05 | 198 | 130 | 6 | 3cdfcc6445858c3c54058bbd90b20b88b1771cca | |
| Drug | cysteine sulfinic acid | 6.15e-06 | 46 | 129 | 5 | CID000000109 | |
| Drug | S-nitrosocysteine | 1.50e-05 | 93 | 129 | 6 | CID003359494 | |
| Drug | Metixene hydrochloride [1553-34-0]; Up 200; 11.6uM; HL60; HT_HG-U133A | 1.64e-05 | 196 | 129 | 8 | 2451_UP | |
| Drug | genistein; Down 200; 10uM; PC3; HT_HG-U133A | 1.70e-05 | 197 | 129 | 8 | 4459_DN | |
| Drug | alpha-estradiol; Up 200; 0.01uM; PC3; HT_HG-U133A | 1.70e-05 | 197 | 129 | 8 | 1210_UP | |
| Drug | aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A_EA | 1.76e-05 | 198 | 129 | 8 | 1042_DN | |
| Disease | Osteogenesis imperfecta | 8.90e-05 | 21 | 123 | 3 | cv:C0029434 | |
| Disease | Skin Ulcer | 1.03e-04 | 4 | 123 | 2 | C0037299 | |
| Disease | Autosomal dominant nonsyndromic hearing loss | 2.39e-04 | 29 | 123 | 3 | cv:C5779548 | |
| Disease | hereditary lymphedema (is_implicated_in) | 3.57e-04 | 7 | 123 | 2 | DOID:0050580 (is_implicated_in) | |
| Disease | neuroticism measurement | PDE1C CELF4 ZMYND8 PLEKHM1 STAB1 PTK2B PTPN14 TENM3 MICAL2 FDFT1 SEMA3B KMT2A | 4.28e-04 | 909 | 123 | 12 | EFO_0007660 |
| Disease | metabolite measurement | SLC24A5 GPAA1 SHMT2 LCP1 STAB1 ARHGAP22 RSAD2 MICAL2 RAB11FIP3 | 5.81e-04 | 560 | 123 | 9 | EFO_0004725 |
| Disease | Osteogenesis imperfecta type IV (disorder) | 7.59e-04 | 10 | 123 | 2 | C0268363 | |
| Disease | Congenital neurologic anomalies | 7.59e-04 | 10 | 123 | 2 | C0497552 | |
| Disease | Cranioschisis | 7.59e-04 | 10 | 123 | 2 | C0265541 | |
| Disease | Osteogenesis imperfecta type III (disorder) | 9.25e-04 | 11 | 123 | 2 | C0268362 | |
| Disease | neuroticism measurement, response to selective serotonin reuptake inhibitor | 9.25e-04 | 11 | 123 | 2 | EFO_0005658, EFO_0007660 | |
| Disease | Osteogenesis Imperfecta | 1.30e-03 | 13 | 123 | 2 | C0029434 | |
| Disease | psychosis | 1.52e-03 | 14 | 123 | 2 | EFO_0005407 | |
| Disease | Acute Myeloid Leukemia, M1 | 1.89e-03 | 125 | 123 | 4 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 1.89e-03 | 125 | 123 | 4 | C1879321 | |
| Disease | cutaneous melanoma, hair color | 2.23e-03 | 62 | 123 | 3 | EFO_0000389, EFO_0003924 | |
| Disease | non-Hodgkin lymphoma (is_implicated_in) | 2.25e-03 | 17 | 123 | 2 | DOID:0060060 (is_implicated_in) | |
| Disease | Child Behaviour Checklist assessment | 2.52e-03 | 18 | 123 | 2 | EFO_0005661 | |
| Disease | creatinine measurement | KRT18 SPEG ACVR2B LCP1 B4GALT1 PTPN14 FDFT1 FNIP1 SGSM3 CTNND1 NLRC3 | 3.02e-03 | 995 | 123 | 11 | EFO_0004518 |
| Disease | response to ziprasidone | 3.12e-03 | 20 | 123 | 2 | GO_0097337 | |
| Disease | Sarcoma | 3.44e-03 | 21 | 123 | 2 | C1261473 | |
| Disease | Nonsyndromic genetic hearing loss | 3.98e-03 | 76 | 123 | 3 | cv:C5680182 | |
| Disease | worry measurement | 4.01e-03 | 154 | 123 | 4 | EFO_0009589 | |
| Disease | obsolete_red blood cell distribution width | GALK1 MYO9B MARK3 RBL1 MYO19 PIEZO1 LRRC37A2 PEPD HSD11B1L LCP1 ESYT3 CD33 TBC1D12 | 4.13e-03 | 1347 | 123 | 13 | EFO_0005192 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DGEEFLFRTGLGILR | 691 | O60347 | |
| GRLAAAFEFLDNERE | 81 | A0FGR9 | |
| GGEDDDIFNRLVFRG | 311 | P15291 | |
| ELIFLARGDAERNIF | 276 | Q9P2K9 | |
| FSRDDIVLDLGFIDG | 921 | Q8WWZ4 | |
| VLRGVDDLDFFIGDE | 51 | Q9P1U1 | |
| DTHNEVRFDRFGDGI | 436 | Q14416 | |
| VFLGGRNRVCFLDDE | 401 | Q4L235 | |
| DGFFGSLRRELDVQD | 186 | Q7Z5J1 | |
| RDGDGEVSEQEFLRI | 151 | P41208 | |
| RFLSRGFEVEEAGAA | 101 | Q8TE56 | |
| QRFRGFGGVRIEEDV | 441 | P12955 | |
| REEGEAFAREHGLIF | 131 | Q8WUD1 | |
| IGVDFEIERFEIAGI | 156 | O95755 | |
| ADRDGAITFQEFARG | 56 | Q8IZ41 | |
| GVEFLNRDLEVDGRF | 41 | Q9NP90 | |
| GDGDGFVRIEDFIQF | 216 | O75154 | |
| FRRVVDFIDEGVNIG | 441 | P34897 | |
| DINVGFDTGDDRLFL | 256 | P48544 | |
| DRGFFEIDQVNGEVR | 611 | Q8TAB3 | |
| QLLDGFVRFVEGLNR | 981 | O75140 | |
| DGINLLGVLEEARFF | 161 | Q7L273 | |
| RRLLEDGEDFNLGDA | 381 | P05783 | |
| GRLFDQRFGEGLLEA | 26 | O14558 | |
| LDGGELFSRIQDRGD | 141 | P49137 | |
| DRRDIFGNEIRDGLV | 296 | P17735 | |
| DRGLLFFAENGDRFI | 2631 | Q16787 | |
| LQEDEEGFSRGIFRF | 1611 | A6NM11 | |
| LQEDEEGFSRGIFRF | 1611 | A6NMS7 | |
| EDGRLDVFLRFLSGL | 506 | Q7RTR2 | |
| EEQFAGGDRARAFAR | 61 | O43292 | |
| RDGNLVEDFVFDAGV | 411 | Q9H9P8 | |
| AREYLREDLQEFLGG | 16 | Q96H55 | |
| EQEGFAEGFVRALAE | 106 | P05412 | |
| GEGERLFDLEETLGR | 301 | Q9HAT1 | |
| QNFIRDVGLADRFEE | 131 | Q9HCE5 | |
| EVQEETQGRFRLLGD | 81 | P20138 | |
| IIRDYLEDQQGGREF | 216 | P37268 | |
| FFRAGVLAQLEEERD | 786 | Q7Z406 | |
| GDLDQDGRISFDEFI | 61 | P13796 | |
| DFGRNGIERYELLQE | 171 | O60245 | |
| EEFFRQGDREAELGL | 396 | Q14123 | |
| AEFFQQGDRERESGL | 566 | Q08493 | |
| EFGRIAVEFLRRGAN | 26 | Q86X83 | |
| ELLAEARRAFREEFG | 11 | P51570 | |
| FGARILDEEVFEGDV | 191 | P13942 | |
| EVGFFDVLGNDRRRE | 131 | Q9H3P7 | |
| FRREEYEGNLLEAGL | 126 | Q5XXA6 | |
| EDGELGFRRGDFIHV | 171 | P62993 | |
| LEDFIRNLRGVDDGA | 806 | Q9UPP2 | |
| EERDGDVDQGFREQL | 746 | Q9BQG0 | |
| LLRFREDSFQVGGGE | 1371 | O75161 | |
| ADEGISFRGLFIIDD | 121 | Q06830 | |
| LEGEARLTFLNRGED | 551 | Q9BZF1 | |
| ERNVEDLSGGELQRF | 211 | P61221 | |
| QRFGRFLGLTERDVE | 266 | P07099 | |
| EELFRRFDKDGNGTI | 81 | Q8WWF8 | |
| GFNDELEAFKERVRG | 251 | Q16543 | |
| DFVLQGIGSDERFRQ | 1011 | Q8TF40 | |
| TFEERDIIEGAFRQG | 421 | O75417 | |
| SRAFRGEQFVLEKGD | 71 | P26998 | |
| RDERGFDILLGLDVN | 226 | Q96P44 | |
| EQRERFLLFCVHGDG | 691 | P27448 | |
| EQFLGFGSDEEVRVR | 146 | Q03164 | |
| FFEGVEARVAQGIRE | 781 | Q9NV70 | |
| RELRFEIGEGENLDL | 186 | Q02790 | |
| AREDVVLNRILGEGF | 421 | Q14289 | |
| FFQGLRLGAELIRED | 136 | Q8TE68 | |
| ENGRLLDFEFSSGRL | 506 | O95479 | |
| DDGFRRLFAQLAGED | 531 | P17655 | |
| LRDKDGQVDARFFGQ | 296 | Q9ULU4 | |
| ARGLLDIFRDFGNNE | 66 | Q9P1A2 | |
| NGRFVGDADLERQKF | 66 | O60716 | |
| FAIDPELRGAEFERI | 516 | Q05469 | |
| VEFFHVEDLEGGIRN | 316 | Q07820 | |
| LSEFEFDVIIGADGR | 211 | O94851 | |
| FDVIIGADGRRNTLE | 216 | O94851 | |
| LPFAVFARLDDEQGR | 171 | P48145 | |
| ERVLRAVGGTLQDFF | 186 | P33402 | |
| AFIGSTEEDDRRLGF | 311 | Q8WU17 | |
| RDAEEGEFLLSFLQG | 156 | Q9Y4G2 | |
| LIFFDEIDAIGGARF | 271 | P35998 | |
| EFDFGSQEIRVGLRQ | 126 | Q8NBV8 | |
| RRRSQKFGVGDDDDF | 331 | Q68CQ4 | |
| EFGRLTRFLAEEQAG | 316 | Q8WV44 | |
| GDEGIFEESFIEERR | 106 | Q9UMY4 | |
| VESLRGFEQERVGLA | 66 | Q9BYD3 | |
| AERFVIGDEEFERFL | 266 | Q8WXG1 | |
| LTVGDFDERIFLGAD | 311 | P28749 | |
| NLEIRRLEDGAEGVF | 416 | P57071 | |
| INEVERLDGFGQEIF | 206 | Q15678 | |
| RIGDEDVGRVIFGLF | 51 | P23284 | |
| FIEEAAGREVERDFA | 591 | Q96HU1 | |
| RQFDDLFRGETGKDR | 221 | Q969X2 | |
| RDIDLKRGFGFVEFE | 31 | Q13243 | |
| RERLGEFLGEDAIAE | 81 | Q5VX52 | |
| DFIRERGLTEEGLFR | 181 | Q7Z5H3 | |
| DDVRRLFEAFGNIEE | 166 | Q9BZC1 | |
| EGAINFQRDAFLRID | 371 | Q13705 | |
| FALNREQGIVGDFDF | 861 | Q9BXU1 | |
| FQLGFEREGVRINDR | 1821 | O75443 | |
| ENGRRVAALGAELFV | 71 | Q6ZTK2 | |
| AAGQEEQELRERAFF | 11 | Q86XI8 | |
| ERGFFEAERDNADRG | 176 | Q13064 | |
| VQGTQRLELRDDGAF | 141 | Q15772 | |
| GDLIEATEFDRLFEG | 56 | Q6NXR4 | |
| QALLVDEERGRLFVG | 56 | Q13214 | |
| GEVGFLAEDRRINVA | 586 | P38935 | |
| FEDLIGEGNFGQVIR | 841 | P35590 | |
| EENGCADFFIRGERL | 51 | Q7Z699 | |
| FILEHGRNEEGIFRL | 186 | P42331 | |
| QRLFQFIGRAAEGAE | 226 | Q9P253 | |
| GALVDQGVFEELARD | 641 | Q6ZT07 | |
| AEEAGAENLFIFGLR | 701 | P11216 | |
| EGFFTRQERRDGGII | 56 | Q71RS6 | |
| FIDEEQAFGVRGQAR | 1051 | Q5JSZ5 | |
| DEDGFLRQRGGDIFE | 2256 | Q6N022 | |
| FLQGALFEEELARLG | 1056 | Q9NY15 | |
| LDEDGFLRQRGTEIF | 2191 | Q9P273 | |
| GNVYVKFRREEDGER | 111 | Q8WU68 | |
| EEERQRGNFPDRFSG | 71 | A0A599 | |
| SDNIDFGRLFGREFV | 171 | P04628 | |
| DERRVKLTDFGFGRQ | 146 | Q9BXA6 | |
| RRLQEFDGAVEDFLK | 296 | Q8NEE8 | |
| EAELFAEGQGRALRL | 1661 | Q92508 | |
| VFAQLQVRGRDFGDL | 56 | C9JI98 | |
| DLIFCADLRGEGEFQ | 141 | Q96IP4 | |
| DDILLGDDGGFVNRF | 226 | B1ANS9 | |
| GADAFERGDFSLRIE | 246 | Q9BRK3 | |
| RAIGLLDIFGFENFE | 431 | Q6PIF6 | |
| IGVLDIFGFEDFERN | 516 | Q13459 | |
| FVIRIEDGNGRRAFI | 91 | Q9NVZ3 |